How many studies have been conducted on Kml29?

BiohacksAI has indexed 6 PubMed studies on Kml29.

What are the main research areas for Kml29?

The primary research domains for Kml29 are 💊 Pain, 🔬 Inflammation, 🧠 Neuroprotection. This is based on analysis of 6 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Kml29

1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo(d)(1,3)dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate [Supplementary Concept] inhibits monoacylglycerol lipase Heading Mapped to: Piperidines Benzodioxoles

6+ PubMed studies analyzed · Evidence Score: 18

Research Domains

Kml29 has been studied across 8 research domains including 💊 Pain, 🔬 Inflammation, 🧠 Neuroprotection, ❤️ Cardiovascular, 🦠 Gut & Microbiome. The primary research focus is 💊 Pain with 50% of studies addressing this area.

Loading evidence profile...

This evidence profile for Kml29 is generated deterministically from 6 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.